Share-Based Compensation (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Share-Based Compensation Expense and Related Tax Benefits |
The table below provides the share-based compensation expense and related tax benefits for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|
|
(in thousands) |
|
Share-based compensation expense |
|
$ |
3,598 |
|
|
$ |
3,575 |
|
|
$ |
2,681 |
|
Related tax benefits |
|
$ |
1,061 |
|
|
$ |
1,065 |
|
|
$ |
808 |
|
|
| Summary of Information under Plans |
The following information under the Plans is presented for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|
|
(in thousands) |
|
Total intrinsic value of options exercised (1) |
|
$ |
— |
|
|
$ |
61 |
|
|
$ |
343 |
|
Cash received from options exercised |
|
$ |
— |
|
|
$ |
582 |
|
|
$ |
— |
|
(1)Intrinsic value represents the difference between the closing stock price on the exercise date and the exercise price, multiplied by the number of options.
|
| Summary of Stock Option Transactions under Plans |
The following is a summary of stock option transactions under the Plans for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|
|
Number of
Shares |
|
|
Weighted-
Average
Exercise
Price Per
Share |
|
|
Number of
Shares |
|
|
Weighted-
Average
Exercise
Price Per
Share |
|
|
Number of
Shares |
|
|
Weighted-
Average
Exercise
Price Per
Share |
|
Options outstanding at beginning of period |
|
|
3,000 |
|
|
$ |
24.83 |
|
|
|
61,000 |
|
|
$ |
22.73 |
|
|
|
111,000 |
|
|
$ |
19.89 |
|
Options exercised |
|
|
— |
|
|
$ |
— |
|
|
|
(25,000 |
) |
|
$ |
25.75 |
|
|
|
(50,000 |
) |
|
23.29 |
|
Options expired |
|
|
(3,000 |
) |
|
$ |
24.83 |
|
|
|
(33,000 |
) |
|
$ |
22.10 |
|
|
|
— |
|
|
$ |
— |
|
Options outstanding at end of period |
|
|
— |
|
|
$ |
— |
|
|
|
3,000 |
|
|
$ |
24.83 |
|
|
|
61,000 |
|
|
$ |
22.73 |
|
Options exercisable at end of period |
|
|
— |
|
|
$ |
— |
|
|
|
3,000 |
|
|
$ |
24.83 |
|
|
|
61,000 |
|
|
$ |
22.73 |
|
|
| Restricted stock awards |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Schedule of Restricted Stock Awards and Performance Stock Units under 2013 And 2021 Plan |
The table below provides information for restricted stock awards under the Plans for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|
|
Number of
Shares |
|
|
Weighted-
Average
Grant Date
Fair Value
Per Share |
|
|
Number of
Shares |
|
|
Weighted-
Average
Grant Date
Fair Value
Per Share |
|
|
Number of
Shares |
|
|
Weighted-
Average
Grant Date
Fair Value
Per Share |
|
Restricted stock at beginning of period |
|
|
259,208 |
|
|
$ |
17.56 |
|
|
|
196,445 |
|
|
$ |
20.72 |
|
|
|
156,174 |
|
|
$ |
21.29 |
|
Restricted stock granted |
|
|
114,203 |
|
|
|
22.96 |
|
|
|
170,541 |
|
|
|
15.69 |
|
|
|
131,021 |
|
|
|
18.86 |
|
Restricted stock vested |
|
|
(133,191 |
) |
|
|
18.51 |
|
|
|
(106,417 |
) |
|
|
19.51 |
|
|
|
(83,968 |
) |
|
|
19.34 |
|
Restricted stock forfeited |
|
|
(10,647 |
) |
|
|
18.85 |
|
|
|
(1,361 |
) |
|
|
18.16 |
|
|
|
(6,782 |
) |
|
|
23.08 |
|
Restricted stock at end of period |
|
|
229,573 |
|
|
$ |
19.64 |
|
|
|
259,208 |
|
|
$ |
17.56 |
|
|
|
196,445 |
|
|
$ |
20.72 |
|
|
| Performance Stock Units |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Schedule of Restricted Stock Awards and Performance Stock Units under 2013 And 2021 Plan |
The table below provides information for performance stock units under the 2021 Plans for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|
|
Number of
Shares |
|
|
Weighted-
Average
Grant Date
Fair Value
Per Share |
|
|
Number of
Shares |
|
|
Weighted-
Average
Grant Date
Fair Value
Per Share |
|
|
Number of
Shares |
|
|
Weighted-
Average
Grant Date
Fair Value
Per Share |
|
Performance stock at beginning of period |
|
|
180,330 |
|
|
$ |
17.44 |
|
|
|
134,358 |
|
|
$ |
21.37 |
|
|
|
104,599 |
|
|
$ |
18.83 |
|
Performance stock granted |
|
|
53,509 |
|
|
|
21.39 |
|
|
|
88,598 |
|
|
|
14.30 |
|
|
|
53,696 |
|
|
|
21.08 |
|
Performance stock vested |
|
|
(32,759 |
) |
|
|
25.10 |
|
|
|
(39,249 |
) |
|
|
18.40 |
|
|
|
(23,937 |
) |
|
|
9.65 |
|
Performance stock forfeited |
|
|
(9,276 |
) |
|
|
21.60 |
|
|
|
(3,377 |
) |
|
|
18.40 |
|
|
|
— |
|
|
|
— |
|
Performance stock at end of period |
|
|
191,804 |
|
|
$ |
17.03 |
|
|
|
180,330 |
|
|
$ |
17.44 |
|
|
|
134,358 |
|
|
$ |
21.37 |
|
|